Full Text
Full Text PDF
Abstract
Non-alcoholic fatty liver disease (NAFLD) is histologically classified as either non-alcoholic fatty liver or non-alcoholic steatohepatitis (NASH). NASH is the progressive subtype of NAFLD. Individuals with NASH are at significant risk of developing hepatic fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related and all-cause mortality. NAFLD is closely associated with obesity, type 2 diabetes mellitus (T2DM), metabolic syndrome, and cardiovascular events. Its prevalence is estimated to be above 30% in Turkey; and recent studies confirm this estimate. According to these studies, the prevalence of NAFLD in Turkey is between 48.3% and 60.1%. Currently, Turkey can be considered a risky region in terms of NAFLD burden as it is the most obese country in Europe with an obesity prevalence of 32.1% according to the 2016 World Health Organization data. Moreover, along with the increasing prevalence of obesity and T2DM in Turkey, the burden of NAFLD is estimated to increase in the upcoming decade. Despite the growing burden, we lack well-designed systemic studies that investigate NAFLD and its marked histological severity. In this review, we present studies on the burden of NAFLD and NASH, the natural history of NAFLD, and its association with other systemic diseases conducted with Turkish populations.
Most read articles by the same author(s)
- Sabahattin Kaymakoğlu, İftihar Köksal, Fehmi Tabak, Ulus S. Akarca, Ayhan Akbulut, Filiz Akyüz, Hürrem Bodur, Atahan Çağatay, Dinç Dinçer, Şaban Esen, Rahmet Güner, Selim Gürel, Şükran Köse, Ömer Şentürk, Halis Şimşek, Tansu Yamazhan, Yusuf Yılmaz, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Recommendation for treatment of hepatitis C virus infection , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Hasan Eruzun, Lars Bossen, Dilara Turan Gökçe, İlkay Ergenç, Zekiye Nur Harput, Neslihan Güneş Aydemir, Meral Akdoğan Kayhan, Hasan Basri Yapıcı, Tugay Doğan, Peter Holland-Fischer, Jesper Bach Hansen, Yusuf Yılmaz, Orhan Sezgin, Haydar Adanır, Ahmet Bektaş, Henning Grønbæk, Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis , Turkish Journal of Gastroenterology: Vol. 36 No. 4 (2025): Turkish Journal of Gastroenterology
- Eda Kaya, Yusuf Yılmaz, Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Cognitive Impairment and All-Cause Dementia: A Comprehensive Review , Turkish Journal of Gastroenterology: Vol. 35 No. 2 (2024): Turkish Journal of Gastroenterology
- Oğuzhan Kesen, Haluk Tarık Kani, Ömer Yanartaş, Umut Emre Aykut, Bedin Gök, Feyza Gündüz, Yusuf Yılmaz, Osman Cavit Özdoğan, Yeşim Özen Alahdab, Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents , Turkish Journal of Gastroenterology: Vol. 30 No. 9 (2019): Turkish Journal of Gastroenterology
- Coşkun Özer Demirtas, Çağlayan Keklikkıran, Shahin Mehdiyev, İlkay Ergenç, Yeşim Özen Alahdab, Feyza Gündüz, Yusuf Yılmaz, Özlen Atuğ, Osman Cavit Özdoğan, Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in Istanbul , Turkish Journal of Gastroenterology: Vol. 32 No. 2 (2021): Turkish Journal of Gastroenterology
- Deniz Guney Duman, Yesim Ozen Alahdab, Coskun Ozer Demirtas, Yusuf Yılmaz, Feyza Dilber, Filiz Ture Ozdemir, Caglayan Keklikkiran, Haluk Tarik Kani, Umut Emre Aykut, Osman Cavit Ozdogan, Usefulness of Endoscopic Ultrasound Strain Elastography for Measuring Liver Stiffness and the Role of Blood Cytokeratin 18 Levels as a Surrogate Marker of Fibrosis , Turkish Journal of Gastroenterology: Vol. 36 No. 10 (2025): Turkish Journal of Gastroenterology
- Feyza Gündüz, Haluk Tarık Kani, Shannon Chang, Esra Akdeniz, Fatih Eren, Yusuf Yılmaz, Yeşim Özen Alahdab, Effect of carbon dioxide versus room air insufflation on post-colonoscopic pain: A prospective, randomized, controlled study , Turkish Journal of Gastroenterology: Vol. 31 No. 10 (2020): Turkish Journal of Gastroenterology
- Yusuf Yılmaz, Haluk Tarık Kanı, Coşkun Özer Demirtaş, Eda Kaya, Aybüke Fatma Sapmaz, Lubna Qutranji, Tasnim Alkayyali, Kerim Deniz Batun, Mahmut Batman, Berk Toy, Aslı Çiftaslan, Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience , Turkish Journal of Gastroenterology: Vol. 30 No. 10 (2019): Turkish Journal of Gastroenterology
- Oya Yonal, Fatih Eren, Yusuf Yılmaz, Özlen Atuğ, Hülya Hamzaoğlu Över, No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects , Turkish Journal of Gastroenterology: Vol. 25 No. 6 (2014): Turkish Journal of Gastroenterology
- Ayşegül Avcu, Eda Kaya, Yusuf Yilmaz, Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic , Turkish Journal of Gastroenterology: Vol. 32 No. 5 (2021): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 30 · Issue 10
Pages
865-871
History
Published Online
October 15, 2019
Copyright
Copyright (c) 2019 Eda Kaya, Yusuf Yılmaz
Affiliations
Eda Kaya
Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Turkey
Yusuf Yılmaz
Department of Gastroenterology, Marmara University Faculty of Medicine, İstanbul, Turkey; Marmara University Gastroenterology Institute, İstanbul, Turkey
Cite this Article
Kaya, E., & Yılmaz, Y. (2019). Non-alcoholic fatty liver disease: A growing public health problem in Turkey. Turkish Journal of Gastroenterology, 30(10), 865–871. https://doi.org/10.5152/tjg.2019.18045
Outlines